JT - Only you can determine the best time for you to enter any position. A 30 million share dilution at this point may actually be very positive for this company. It will tell the market the company has enough money to get past the Top Line results mark and have enough to do the BETonRENAL PhaseII trial which could be viewed as very positive. Depending on what the SSA results say, that could be quite positive as well, or not. As long as you understand that an investment in a development biotech company is close to the top of the investment risk spectrum and you could make or lose a bunch of money then make the best decision you can with the available information. Maybe one or more of the LOI's will come through and reduce or eliminate the need for any dilution. Most of all make your own decision, you are the only one you get to look at in the mirror each morning.

dyodd

tada